Vaccine Formulation, Stability & Delivery Options — Hands-on

Connect immunoinformatics designs to real world vaccine products. This module develops an intuitive, non mathematical view of formulation building blocks, stability and degradation concepts, delivery platforms and program constraints so that teams can translate epitope and antigen ideas into feasible vaccine formulations and delivery strategies.

Vaccine Formulation, Stability & Delivery Options

Help Desk · WhatsApp

Session Index

Session 1 — Formulation Building Blocks & Modalities Session 2 — Stability & Degradation Pathways (Concepts) Session 3 — Delivery Options & Program Constraints Session 4 — Design Brief: Formulation & Delivery Plan

Session 1

Fee: Rs 8800

Formulation Building Blocks & Modalities

Antigen, adjuvant and excipient roles in simple language

antigen as information and immune target adjuvants as danger signal helpers in concept excipients as stabilisers and carriers overview

Main vaccine modalities in overview (no manufacturing detail)

protein and peptide formulations in concept inactivated, subunit and vector based vaccines overview nucleic acid and nanoparticle style ideas in plain language

Linking immunoinformatics outputs to formulation thinking

from epitope lists to antigens that can be formulated multi epitope constructs and carrier ideas conceptually how antigen format choices affect formulation options

Session 2

Fee: Rs 11800

Stability & Degradation Pathways (Concepts)

What stability means for a vaccine product (non mathematical)

potency over time as a core idea physical versus chemical stability in simple terms visible and invisible changes that matter for performance

Common degradation pathways at a high level

aggregation and denaturation concepts hydrolysis, oxidation and deamidation narratives for nucleic acid formats, simple breakdown and hydrolysis notions

Temperature, light and handling stresses in story form

cold chain and excursions as practical challenges repeated freeze thaw and agitation ideas buffer and excipient choices as part of stability thinking

Session 3

Fee: Rs 14800

Delivery Options & Program Constraints

Main delivery routes and devices in overview (no engineering detail)

intramuscular and subcutaneous injections conceptually intranasal, oral and mucosal delivery ideas needles, syringes and alternative devices in simple language

Program and deployment constraints that influence choices

cold chain infrastructure and site capabilities target population, dosing schedule and setting cost, scale and access considerations in concept

Matching immunological goals to practical delivery options

systemic versus mucosal response orientation prime boost and heterologous regime ideas connecting desired profile to realistic platforms

Session 4

Fee: Rs 18800

Design Brief: Formulation & Delivery Plan

Summarising antigen, formulation and delivery choices in one view

simple table of antigen format and adjuvant concept intended route, schedule and target group notes stability and cold chain assumptions listed clearly

Highlighting risks, trade offs and open questions honestly

where data is strong versus tentative in concept alternative options if constraints change dependencies on manufacturing and regulatory paths

Packaging the plan for internal and partner discussions

slide ready schema of formulation and delivery concept short narratives tailored to scientific and business teams handoff to CMC, clinical and regulatory colleagues in principle

PDF

Vaccine Formulation, Stability & Delivery Options Training | From Immunoinformatics to Practical Products

Vaccine Formulation, Stability & Delivery Options — Hands-on